Sef Davorin, Kabir Tito, Lees Nicholas James, Stock Ulrich
Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Department of Cardiology, Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
J Card Surg. 2021 Mar;36(3):1062-1066. doi: 10.1111/jocs.15303. Epub 2021 Jan 6.
Despite clear clinical benefits, there is limited evidence regarding possible complications of the novel mechanical support device Impella. Aortic and mitral valve regurgitation or injury are rare but potential complications following implantation of the Impella device.
To evaluate valvular complications after the Impella device implantation, we have performed a comprehensive search of literature on multiple sites on this topic.
Ten case reports and one observational retrospective study were identified, with a total number of 19 patients identified. This article aims to draw attention to potential periprocedural complications relating to the Impella, in particular iatrogenic aortic and mitral valve injuries. Moreover, we have summarized our recommendations emphasizing the need for careful management and meticulous follow-up of these patients to avoid such potentially devastating complications.
尽管新型机械支持装置Impella具有明确的临床益处，但关于其可能的并发症的证据有限。主动脉瓣和二尖瓣反流或损伤虽罕见，但却是Impella装置植入后的潜在并发症。
为评估Impella装置植入后的瓣膜并发症，我们在多个网站对该主题的文献进行了全面检索。
共识别出10例病例报告和1项观察性回顾性研究，总计19例患者。本文旨在引起对与Impella相关的围手术期潜在并发症的关注，尤其是医源性主动脉瓣和二尖瓣损伤。此外，我们总结了建议，强调对这些患者进行仔细管理和精心随访以避免此类潜在灾难性并发症的必要性。
